ABK Biomedical

ABK Biomedical is a research and development company innovating next generation embolotherapeutic products and delivery devices for the treatment of uterine fibroids, hypervascularized tumours, and arteriovenous malformations.

The company is driven by the unmet clinical need to develop integrated solutions (devices and instruments) to simplify embolotherapy procedures performed by interventional radiologists, particularly uterine fibroid embolization (UFE). 

ABK Biomedical is located in Halifax, NS, and was co-founded at Dalhousie University by interventional radiologist, Dr. Bob Abraham, and materials scientists Daniel Boyd and Sharon Kehoe.

32-155 Chain Lake Drive
Halifax, NS B3S 1B3